MENU
ARVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arvinas (ARVN) Ownership - Who owns Arvinas?

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
574.86M
P/E Ratio
N/A
Total Cash
861.2M
Projected Growth
N/A
Total Debt
9.9M
Revenue
372.8M
Risk (Beta)
2.16
Dividend Yield
N/A
Total Cash/Share
11.73
Total Debt/Equity
N/A
Revenue/Share
5.14 USD as % of share price

Fundamentals

ARVN
Capitalization
575M
P/E Ratio
N/A
Risk (Beta)
2.16
Dividend Yield
N/A
Total Cash
861M
Total Cash/Share
11.73
Total Debt
9.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.14%
Revenue
373M
ROE
N/A
Book Value
609M
P/B Ratio
0.94
Cash Flow
N/A
Earnings
-1.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
5.64
Current Revenue Per Employee
52093.02
Dividends Per Share - Security
N/A
EBITDA
-112.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-6.63
Shares Held By Institutions
743M
Shares Outstanding - Current
73.4M
Total Liabilities
300M
Total Volume MTD
N/A
Value
1
Gain YTD
-60.303
View a ticker or compare two or three
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARVN showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com